Abstract Details
PRESENTER |
No disclosure on file |
No disclosure on file | |
David J. Roh, MD (Columbia University Medical Center) | Dr. Roh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Portola Pharmaceuticals. |
Soojin Park, MD | Dr. Park has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical Care. The institution of Dr. Park has received research support from National Institutes of Health. |
Jan Claassen, MD, PhD (Columbia University College of Physicians & Surgeons) | Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care. |
No disclosure on file | |
Sachin Agarwal, MD, MPH (Columbia University Med Center) | Dr. Agarwal has nothing to disclose. |